InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
59,897.89
(
1.12%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Headache

Send PM Follow Ignore
Followers 1
Posts 313
Boards Moderated 0
Alias Born 06/16/2005

Headache

Re: Kag post# 3984

Tuesday, 05/30/2006 11:02:20 AM

Tuesday, May 30, 2006 11:02:20 AM

Post# of 30387
Rather than continuing to fret about Kag's hermeneutical treatment of the latest PRs, I decided to ask Dr. Moro whether the statement that "We do not know yet if the normal RECAF concentration is constant enough to make this personalization possible" from the May 16 release has any bearing on the standard assay. He basically said it does not, reiterating the natural interpretation (at least for me) of the PR that he was discussing a possible improvement of the test when he made the remarks about personalization. Nothing in the PR should be construed as casting the RECAF enterprise into doubt. If you really need him to reiterate the contents of the PR for you you, by all means contact him. But I suggest we just let him get back to fighting the good fight.

END OF STORY. Let's move on now.


Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up